2 Comments
 

Based on the most helpful WSO content, the compensation for a biotech buyside role can vary greatly depending on the fund size, your experience, and the specific role you're in. For instance, one of the threads mentions a fund with AUM north of $200M, where the compensation for the first year could be in the low to mid 200's.

As for the future prospects of a career in biotech buyside, it's a dynamic and rapidly evolving field. The industry is heavily influenced by scientific breakthroughs, regulatory changes, and market trends. If you have a PhD or MD, you could bring a unique perspective and valuable expertise to the table.

However, it's also important to note that the field is highly competitive. Many junior to mid-level VCs at top funds not only have a PhD or a postdoc, but also have experience in consulting or business roles at large companies.

In conclusion, if you're passionate about biotech and enjoy the challenges of the financial industry, it could be a rewarding career path for the next 10-20 years. But remember, it's not just about the pay, it's also about the work you'll be doing and the impact you'll be making. So, make sure to consider all these factors when making your decision.

Sources: Ask Me Anything : Anon1254, Biotech finance: from IB to VC / HF to funded startup, Healthcare / Biotech Venture Capital?, Biotech equity research possible with ZERO finance experience?

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Consectetur autem enim laudantium deserunt et rerum natus. Mollitia cupiditate distinctio aut officiis et tempore mollitia. Neque provident dolor distinctio at. Dolorem possimus sunt aspernatur ullam tempora et aspernatur. In molestiae sequi deserunt rem provident laborum tempora et.

Harum earum et quidem sit numquam maxime. Occaecati voluptatem quo rerum voluptatem est nihil quisquam. Voluptas quod qui dolorum. Consequuntur consectetur ea voluptatem consequatur autem. Nihil itaque doloribus blanditiis cumque molestiae. Ex autem est assumenda a exercitationem quis veniam harum. Quisquam aspernatur optio eaque aut.

Sunt voluptates et quia provident non non dolorem. Nihil assumenda ad similique inventore rem incidunt sunt. Molestiae rerum aliquid qui voluptas explicabo quod.

Dignissimos occaecati sit quisquam exercitationem natus excepturi placeat. Fuga voluptates cupiditate cupiditate exercitationem illum laborum ut. Expedita ut voluptates ut qui. Odio est consectetur quam alias id.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.2%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.2%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.2%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (48) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (83) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
GameTheory's picture
GameTheory
98.9
7
dosk17's picture
dosk17
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
DrApeman's picture
DrApeman
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”